Company: RGNT
Filing Date: 2025-01-27
Form Type: DRS/A
Source: 0001213900-25-006676
Chunk: 276

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-01-27
Form: DRS/A
Chunk 276
---
 related to issuance of warrants |     |   | (288 | ) |
| Amortization of loan discount                 |     |   |  173 |   |
| Balance as of December 31, 2023               |     | $ |  210 |   |

In April 2024, the Company received
the grant from the Horizon 2020 Program and as such, repaid the outstanding balance of the loan (refer to Note 14).

<div align='center'>F-29</div>

REGENTIS BIOMATERIALS LTD.

NOTES TO FINANCIAL STATEMENTS

U.S. dollars in thousands, except share and per share data

| NOTE 6:- | CONVERTIBLE NOTES |

| a. | During 2020, the Company entered into various Convertible Loan Agreements (the “2020 CLAs”). As of December 31, 2020, the Company received $500 from the issuance of convertible notes (the “2020 Notes”) under the 2020 CLAs. In 2021, the Company received an additional $400. |

The 2020 Notes bears no interest and,
unless previously converted (see below), shall become fully due and payable in cash following 1 year from each 2020 CLA issuance date.

The 2020 Notes may be converted into
most senior securities of the Company or repaid as follows:

| 1. | Automatic conversion upon occurrence of a qualified round – upon the closing of a qualified round (transaction or series of related transactions in which shares of the Company having substantially similar rights are issued for an aggregate investment amount of at least $ 3,000), the 2020 Notes shall be automatically be converted into such number of shares of the most senior securities issued in such qualified round, based on a price per share equal to 80% of the lowest price per share actually paid by any investor in the qualified round. |

| 2. | Automatic conversion upon occurrence of a merger and acquisition transaction – upon the closing of merger and acquisition transaction (as defined in the 2020 CLAs), the 2020 Notes shall be automatically converted into Company’s most senior securities, based on a price per share equal to 80% of the lowest price per attributed to such securities in the merger and acquisition transaction. |

In October 2021, the Company entered
into an agreement with the 2020 CLA investors to extend the due dates of the 2020 Notes until June 2022 (which